リボシクリブの包括的な安全性評価:FDAの有害事象報告システム (FAERS) データベースを用いた現実世界の分析
Lan Luo1, Yue Wang1, Yumei Fu1
1Department of Breast Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
British journal of clinical pharmacology
|September 2, 2025
まとめ
この研究では,乳がん薬であるリボシクリブに関する9533件の有害事象報告を分析した. 既知かつ予期せぬ副作用を特定し,その中には腫瘍や免疫系障害が含まれ,実際の安全性に関する洞察を提供しました.
科学分野:
- 薬剤監視と医薬品の安全性
- 腫瘍学
- 臨床薬理学
背景:
- リボシクリブは,進んだHR+乳がんに対するFDA承認のサイクリン依存キナーゼ4/6 (CDK4/ 6) 阻害剤です.
- 薬物の安全性を理解するには,市場公開後の監視が不可欠です.
研究 の 目的:
- データマイニングを使用してリボシクリブに関連した有害事象 (AE) を評価する.
- 現実世界の安全データ分析を通じて,潜在的に新しい予期せぬAE信号を特定する.
主な方法:
- 2017年Q1から2023年Q1までの米国食品医薬品局の有害事象報告システム (FAERS) データベースを利用した.
- AE信号を検出するために不均衡分析 (ROR,PRR,BCPNN,EBGM) を採用した.
- 規制活動の医学辞書 (MedDRA) を用いて分類した結果.
主要な成果:
- 23の臓器系クラス (SOC) でリボシクリブに関する9533のAE報告を分析した.
- 腫瘍形成と血液学的な毒性に関連したシグナルを持つ腫瘍と免疫系障害を含む重要なSOCを特定した.
- 左心房の拡大,エリシペラ,多神経症,小球膜の濾過率の低下,アゲウシアなどの予期せぬ有害事象が発見されました.
結論:
- リボシクリブの販売後の安全性に関する実用データです.
- リボシクリブ治療に関連した新たな予期せぬ有害事象の兆候を強調しています.
関連する概念動画
01:19Pharmacovigilance
983
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
983
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
01:11Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
01:26Drug Administration and Therapy Phases: Overview
738
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
738
01:12Relative Risk
340
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
340
01:16Clinical Trials
7.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
7.8K